{"id":657834,"date":"2026-10-17T20:32:23","date_gmt":"2026-10-17T20:32:23","guid":{"rendered":"https:\/\/www.newsbeep.com\/ie\/657834\/"},"modified":"2026-10-17T20:32:23","modified_gmt":"2026-10-17T20:32:23","slug":"new-measures-to-improve-messaging-on-antidepressant-risks-announced","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ie\/657834\/","title":{"rendered":"New measures to improve messaging on antidepressant risks announced"},"content":{"rendered":"<p>The UK\u2019s medicines watchdog has announced a series of measures to strengthen messaging around key risks associated with <a href=\"https:\/\/www.thepharmacist.co.uk\/in-practice\/effective-antidepressant-medication-reviews-key-points-for-practice-and-community-pharmacists\/\" rel=\"nofollow noopener\" target=\"_blank\">antidepressant medicines<\/a>.<\/p>\n<p>The measures include new boxed warnings carrying information on suicidal thoughts and behaviours and signposting where patients can get help.<\/p>\n<p>And new patient cards will be available in digital or hard copy formats to reinforce key safety messages.<\/p>\n<p>The Medicines and Healthcare products Regulatory Agency (MHRA) said the changes come in response to concerns raised by patients and families about how information on suicidal thoughts and behaviours and sexual dysfunction are communicated to patients.<\/p>\n<p>Dr Alison Cave, MHRA chief safety officer, said the aim was not to discourage the use of antidepressants but to improve the \u2018prominence and clarity\u2019 of the existing warnings.<\/p>\n<p>She added: \u2018These measures will help ensure patients, carers and healthcare professionals can have more informed conversations about the benefits and risks associated with antidepressant medicines, and better support people throughout their treatment.<\/p>\n<p>\u2018Antidepressants are effective medicines for the treatment of depression and other conditions. When used appropriately and under clinical supervision, for the vast majority of individuals, the benefits outweigh the risks.<\/p>\n<p>\u2018The aim is not to discourage use, but to improve the prominence and clarity of the existing warnings. It\u2019s imperative that patients do not stop taking these medicines without first speaking to their healthcare professional.\u2019<\/p>\n<p>The new safety measures follow a detailed review into how the risks of suicidal thoughts and behaviours, and persistent sexual dysfunction are communicated in the patient information leaflets that accompany antidepressant medications.<\/p>\n<p>The review was initiated by the Commission on Human Medicines (CHM), and the MHRA said that throughout the process it engaged directly with patients and families and considered the latest available evidence and expert clinical advice.<\/p>\n<p>Patient information leaflets for antidepressants will be updated, including a new boxed warning signposting to information on suicidal thoughts and behaviours.<\/p>\n<p>The agency said it is expected that a new patient card will be included in or on the medicine box to reinforce key safety messaging and help patients and carers understand how and when to get further support.<\/p>\n<p>Initially, the cards will be available electronically and may be given to patients by dispensers ahead of the hard copy format becoming available, which is expected to be credit card sized.<\/p>\n<p>And patient information leaflets for certain antidepressants will be updated to include the term \u2018post SSRI sexual dysfunction\u2019 (PSSD), to explain the risk of symptoms continuing after stopping treatment.<\/p>\n<p>In addition, a supporting safety leaflet will be given to patients at their first appointment discussing antidepressants describing the key risks and benefits of the treatment \u2018to support informed decision making\u2019.<\/p>\n<p>The MHRA said it is developing the leaflet in collaboration with the wider healthcare system, and it will be made available in 2027.<\/p>\n<p>The <a href=\"https:\/\/www.gov.uk\/drug-safety-update\/antidepressants-new-safety-measures-for-all-patients-to-improve-communication-of-the-risk-of-suicidal-thoughts-and-behaviours-and-persistent-sexual-dysfunction\" rel=\"nofollow noopener\" target=\"_blank\">agency\u2019s advice for healthcare professionals<\/a>, published yesterday, is to discuss the risk of suicidal thoughts and behaviours with patients when initiating or changing the dose of an antidepressant, or at their next review.<\/p>\n<p>Patients should be advised to seek urgent medical attention if they experience new or worsening feelings of suicidal intent in relation to starting an antidepressant, especially early in treatment or following dose changes.<\/p>\n<p>They should be advised that they can call NHS 111, their local mental health crisis team, the Samaritans on 116 123, or text \u2018SHOUT\u2019 to 85258.<\/p>\n<p>Patients starting or changing a dose should also be made aware that there is evidence that some antidepressants (citalopram, escitalopram, duloxetine, fluvoxamine, fluoxetine, paroxetine, sertraline, venlafaxine, amitriptyline and nortriptyline) are associated with a risk of sexual dysfunction and that symptoms may continue after stopping treatment.<\/p>\n<p>National Institute for Health and Care Excellence (NICE) guidelines should be followed and patients regularly monitored after starting treatment, with the ancillary leaflet given once it becomes available to support discussions.<\/p>\n<p>Patients should also be advised not to stop taking the medicine without first talking to their healthcare professional.<\/p>\n<p>Following the CHM advising several actions for the wider healthcare system on the risk of suicidal thoughts and behaviours in patients taking antidepressants, the MHRA said it is \u2018coordinating actions over the coming months\u2019.<\/p>\n<p>This includes considerations relating to updates of relevant NICE guidance, updates to the British National Formulary, work with the Royal Colleges of General Practitioners, Psychiatrists and Pharmacy, and NHS guidance.<\/p>\n<p>Chris Bird, programme manager for patient safety at NICE, said: \u2018As with all new safety advice issued from the MHRA, we will consider the implications of this advice on published NICE guidance and review our recommendations if required.\u2019<\/p>\n<p>If you are affected by the issues discussed in this story, you can access information and support from the Samaritans charity for free on 116 123 or visit <a href=\"https:\/\/www.samaritans.org\/\" rel=\"nofollow noopener\" target=\"_blank\">samaritans.org<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"The UK\u2019s medicines watchdog has announced a series of measures to strengthen messaging around key risks associated with&hellip;\n","protected":false},"author":2,"featured_media":657835,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[103,61,60],"class_list":["post-657834","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","tag-health","tag-ie","tag-ireland"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/657834","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/comments?post=657834"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/657834\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media\/657835"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media?parent=657834"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/categories?post=657834"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/tags?post=657834"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}